Chen, Emmalyn
Cario, Clinton L.
Leong, Lancelote
Lopez, Karen
Márquez, César P.
Chu, Carissa
Li, Patricia S.
Oropeza, Erica
Tenggara, Imelda
Cowan, Janet
Simko, Jeffry P.
Chan, June M.
Friedlander, Terence
Wyatt, Alexander W.
Aggarwal, Rahul
Paris, Pamela L.
Carroll, Peter R.
Feng, Felix
Witte, John S.
Funding for this research was provided by:
UCSF Moritz-Heyman Discovery Fellows Program
UCSF Goldberg-Benioff Program in Cancer Translational Biology
National Institutes of Health (R01 CA088164)
Article History
Received: 23 October 2020
Accepted: 17 February 2021
First Online: 3 March 2021
Competing interests
: JM Chan: Spouse is a full-time employee of GRAIL, Inc. JS Witte: Non-employee founder of Avail Bio, Inc. R Aggarwal: Honoraria (Clovis Oncology), Consulting or Advisory Role (AstraZeneca, Janssen, Dendreon), Research Funding (Zenith Epigenetics, Novartis, Xynomic Pharmaceuticals Inc., Cancer Targeted Technology, Janssen, Merck, Abbvie, Amgen), Travel and Expenses (Xynomic Pharmaceuticals). CL Cario: currently employed at Avail Bio, Inc. AW Wyatt: Commercial Research Grants (Janssen), Honoraria (AstraZeneca, Bayer, and Janssen). F Feng: Consulting or Advisory Role (Blue Earth Diagnostics, Celgene Corp, Genentech, Janssen Oncology, Bayer, Sanofi, Myovant Sciences Inc, Riovant Sciences Ltd, Astellas Pharma Inc), Commercial Research Grants (Zenith Epigenetics), Founding Member (PFS Genomics), Intellectual Property (University of Michigan). T Friedlander: Honoraria (Astellas, AstraZeneca, EMD Serono), Consulting or Advisory role (Seattle Genetics, Pfizer, EMD Serono, Janssen, Abbvie, Dendreon, Dava Oncology), Research Funding (Janssen, Seattle Genetics, Incyte, Bristo Myers Squibb, Neon Therapeutics, Roche/Genentech). L Leong: currently employed at Parker Institute for Cancer Immunotherapy. E Chen, K Lopez, C Márquez, C Chu, P Li, E Oropeza, I Tenggara, J Cowan, J Simko, P Paris, and P Carroll have no conflict of interest to declare.